Quintara offers custom LNP formulation services to support the identification of high-efficiency, low-toxicity, and stable delivery systems. Our platform delivers comprehensive support for preclinical in vitro and in vivo studies, accelerating the development of innovative nucleic acid therapeutics.
Launch Promotion
Offer:
IVT mRNA Synthesis & LNP Encapsulation Bundle
• Research Grade: 10% OFF
• Preclinical Grade: 15% OFF
Terms and Conditions:
• The promotional pricing applies to all qualifying LNP Encapsulation Service orders and is available to all customers.
• Contact sales.us@quintarabio.com for your personalized quote and discount.
• Quintara Biosciences reserves all rights to this promotion.
High encapsulation efficiency
Reduced immunogenicity and toxicity
High delivery efficiency of mRNA
Validated commercial lipids
Recommended formulations with clear IP ownership
Client-supplied lipids
Preclinical grade: Batches up to 1000 mL
Seamless transition from preclinical research to clinical-stage development
Integrated solutions: From gene synthesis to delivery-ready mRNA-LNP products
Rapid turnaround: As fast as 4 weeks starting from CDS sequence
Fast turnaround
Highest level of accuracy
Free-to-operate plasmid backbone available
Validated UTR sequences
Stable Poly (A) tail
dsRNA reduced synthesis options
Non-infringing cap analogs and enzyme options
Purification options for various applications
Load from 0.5 mg to 100 mg of mRNA
Multiple lipid and formulation options
High encapsulation efficiency
Comprehensive testing panels
Additional testing options available
Standard Report of Analysis (RoA) provided
Research Grade | Preclinical Grade | |
Payload* | mRNA, saRNA | mRNA, saRNA |
Scale | 0.5 - 5mg | 10 -100 mg |
| Turnaround Time+ | 5-7 Business days | 7-9 Business days |
Deliverables | a)Individual cryotubes b)RoA | a)Individual cryotubes b)RoA |
* Additional payload types available upon request.
+ Only the LNP Encapsulation Service turnaround time is shown. For the complete project timeline, please contact us sales.us@quintarabio.com or place an order to view the Order Preview.
| Item | Method | Standard | Research Grade | Preclinical Grade |
| Appearance | Visual inspect | Clear and free of foreign particles |  | |
Concentration | RiboGreen | 0.05 – 0.4 mg/mL | | |
Encapsulation Efficiency | RiboGreen | > 85% | | |
Integrity | Capillary Electrophoresis | <4k nt: ≥75% >4k nt: report value |  | |
Particle Size | DLS | MC3-LNP 80-110 nm | | |
SM102-LNP 65-125 nm | ||||
LP01-LNP 65-125 nm | ||||
ALC0315-LNP 50-100 nm | ||||
Novel lipid: report value | ||||
PDI | DLS | Commercial lipids< 0.2 | | |
Zeta Potential | Zetasizer | ± 20.0 mV | | |
pH | pH Meter | 7.4 ± 0.5 | | |
| Endotoxin | Semiquantitative | <10EU/mg | | |
| Bioburden | Direct inoculation | No growth after 72 hrs | |  |
* ×: Not Included √: Included +: Optional
Quintara offers a flexible mRNA synthesis platform supporting preclinical in vitro, in vivo.
Discover more
Precision and custom gene synthesis from Quintara Biosciences for your research needs.
Discover more
High-quality plasmid DNA with 100% full-sequence accuracy and guaranteed yield.
Discover more
Gene Synthesis - Linear Plasmid - mRNA Synthesis - LNP Encapsulation
We Go Fast, You Go Forward
sales.us@quintarabio.com
1-617-789-6111
3563 Investment Blvd, #2, Hayward, CA 94545sales.us@quintarabio.com1-617-789-611165 Grove St, Suite 102, Watertown, MA 02472sales.us@quintarabio.com1-346-239-997110410 Corporate Dr. Suite 118, Sugar Land, TX 77478sales.us@quintarabio.com
1-424-549-091110601 Virginia Avenue, Culver City, CA 90232sales.us@quintarabio.com1-619-823-08956364 Ferris Square, Suite 102, San Diego, CA 92121Quintara Biosciences © 2025 All Rights Reserved | Site Map | Terms of Use | Privacy Policy
Login 
Order
Contact Us
Contact Us
